— Know what they know.
Not Investment Advice
Also trades as: OBSN.SW (SIX) · $vol 0M

OBSV NASDAQ

ObsEva S.A.
1W: -4.5% 1M: -17.5% 3M: -57.1% 1Y: -94.0% 3Y: -96.3%
$0.10
Last traded 2023-04-24 — delisted
NASDAQ · Healthcare · Biotechnology · $11.0M mcap · 94M float · 8.50% daily turnover

Cash Flow Trends

Operating Cash Flow
-$23M +67.1% ▲
Capital Expenditures
$3K +121.4% ▲
5Y CAGR: -77.5%
Free Cash Flow
-$23M +67.1% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$40M -268.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$77M-$109M-$83M-$58M-$30M
Depreciation & Amort.$109K$737K$721K$736K$567K
Stock-Based Comp.$9M$12M$7M$6M$6M
Change in Working Capital$4M$4M$1M-$2M-$11M
Other Non-Cash Items-$500K$2M$3M-$16M$12M
Operating Cash Flow-$64M-$91M-$71M-$70M-$23M
— Investing Activities —
Capital Expenditures-$188K-$5M-$5K-$14K$3K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$83K$0$0$22M$0
Investing Cash Flow-$271K-$5M-$5K$22M$3K
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$92M$27M$32M$71M-$17M
Financing Cash Flow$92M$27M$32M$71M-$17M
Net Change in Cash$28M-$69M-$38M$24M-$40M
Cash End of Period$139M$69M$31M$55M$15M
Free Cash Flow-$64M-$96M-$71M-$70M-$23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms